Brahman Capital Management Adopts FAIT’s AI-Driven OTC Derivatives Reporting Platform

Quick Summary

Brahman Capital Management has deployed FAIT’s OTC derivatives reporting platform to automate compliance with Monetary Authority of Singapore (MAS) regulations. By utilizing AI-driven integration, the firm now manages trade, valuation, and collateral reporting with full field-level lineage, ensuring accurate regulatory submissions and reduced operational overhead.

How Does FAIT Simplify OTC Derivatives Reporting for Managers?

OTC derivatives reporting remains one of the most complex regulatory hurdles for investment managers due to the high volume of data points required by the Monetary Authority of Singapore. FAIT solves this by replacing brittle, manual mapping with AI-assisted transformation and governed workflows. This transition allows firms like Brahman Capital Management to move away from legacy structures toward a transparent operating model.

• End-to-end visibility into how every reported field is sourced and mapped.
• Automated ingestion and transformation of multi-source trade data.
• Full audit trails that allow compliance officers to stand behind MAS obligations.

What Results Has AI-Driven Integration Delivered for Brahman?

The deployment of AI-driven integration has enabled Brahman Capital Management to achieve MAS-compliant reporting without the need for a heavyweight, multi-year implementation. By focusing on operational transparency, the platform ensures that the reporting burden remains proportionate to the firm's size while maintaining rigorous data integrity across trades, valuations, and collateral.

• Multi-source support for complex OTC derivatives workflows.
• Field-level lineage providing human oversight over AI-assisted processes.
• Rapid deployment compared to traditional reporting middleware solutions.

“As a regulated investment manager, our priority is that reporting is accurate, well-controlled and fully auditable — and that the operational burden on our team stays proportionate," said Rachel Ang, Chief Operating Officer of Brahman Capital Management. "FAIT gives us end-to-end visibility into how each reported field is sourced, mapped and submitted, which is what we need to stand behind our MAS obligations with confidence.”

How Does FAIT Ensure Long-Term Regulatory Compliance?

FAIT’s platform is built to handle the evolving nature of OTC derivatives reporting by providing a scalable infrastructure that adapts to new regulatory requirements. The AI-driven platform automates the reconciliation and submission process, reducing the risk of manual entry errors and ensuring that all data is fully auditable for regulators.

"Brahman is exactly the kind of partner FAIT was built to serve — disciplined, operationally rigorous, and focused on getting reporting right rather than just getting it done," said Aaron Hallmark, Co-Founder and CEO of FAIT. "That's why we built FAIT around AI-driven integration: so a regulated investment manager can operate MAS-compliant trade, valuation and collateral reporting with full field-level lineage and human oversight — and do it without a multi-year, heavyweight implementation."

FF NEWS TAKE:

This deployment moves the needle by proving that AI can solve the "last mile" of OTC derivatives reporting without the typical integration nightmare. For Singapore's buy-side, the ability to achieve MAS compliance through FAIT’s AI-driven integration suggests a shift away from expensive legacy middleware. Brahman’s adoption signals that operational transparency is now a competitive necessity, not just a regulatory checkbox.